|
||
|
||
|
||||||
| Start of second clinical phase II study with FOSALVUDINE ...more |
| Clinical effectiveness of Fosalvudine (HIV) confirmed ...more |
| Fosfluridine Tidoxil shows effectiveness in Actinic Keratosis ...more |
| Recruitment completed for phase IIa trial with fosfluridine tidoxil ...more |
| For meeting with company delegates |
| BIO 2008 (San Diego, CA, USA): June 17-20, 2008 |
| Heidelberg Pharma is a pure-play drug-development company, dedicated to the development of patented drugs in the disease areas of cancer and HIV. Heidelberg Pharma currently has three promising drug candidates under clinical development. | |
 |
|
| Read our Corporate Fact Sheet: | |
 |
Corporate Fact Sheet [105 kB] |
